Related Experiment Video
Updated: May 22, 2025
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Improving Depression Detection and Measuring Its Impact upon Short-Term Survival in Chronic Limb-Threatening Ischemia
Cuneyt Koksoy1, Ilse Torres Ruiz1, Xin Yee Ooi1
1Division of Vascular Surgery and Endovascular Therapy, Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX.
Background:
Depression is underdiagnosed in chronic limb-threatening ischemia (CLTI) patients, and its impact on outcomes is unclear. This study aims to evaluate a CLTI-specific questionnaire designed to detect depression and anxiety, as well as to quantify its impact on early outcomes.
Methods:
A serial cross-sectional study was conducted over the following 2 4-month periods: block I, which retrospectively examined depression prevalence based on medical records, and block II, which prospectively assessed depression using a CLTI-specific questionnaire. Patients were followed for 6 months to assess early outcomes. Data on demographics; comorbidities; wound, ischemia, foot infection (WIfI) grades; perioperative and 6-month limb salvage; and survival were collected and analyzed.
Results:
We evaluated 101 CLTI patients (58 in block I; 43 in block II; median age 68 years [interquartile range 62-74]; 67 [66.3%] male). In block I and block II, 20.7% and 23.3% (P = 0.76), respectively, had a prior depression diagnosis. The CLTI-specific questionnaire in block II showed a median depression score of 22 (interquartile range 19-33), identifying 32.6% with moderate/severe depression and 11.9% more patients compared to chart review alone. Active smoking (hazard ratio 5.16, 95% confidence interval 1.9-14.1) and WIfI clinical stage 4 (hazard ratio 4.69, 95% confidence interval 1.39-15.75) were significantly associated with depression. At 6 months, patients with depression had higher rates of major amputation (18.2% vs. 4.0%; P = 0.02) and mortality (27.3% vs. 6.3%; P < 0.01).
Conclusions:
The overall prevalence of depression in CLTI patients is 32.6%. Our novel CLTI-specific questionnaire detects 12% more cases of moderate/severe depression compared to chart review alone. Depression was linked to higher 6-month mortality, though confounders like smoking and WIfI stage 4 may contribute. Identifying and treating depression in high-risk CLTI patients could improve outcomes.
